Viatris Income After Taxes 2010-2024 | VTRS

Viatris annual/quarterly income after taxes history and growth rate from 2010 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
  • Viatris income after taxes for the quarter ending September 30, 2024 was $0.095B, a 71.41% decline year-over-year.
  • Viatris income after taxes for the twelve months ending September 30, 2024 was $-0.883B, a 148.23% decline year-over-year.
  • Viatris annual income after taxes for 2023 was $0.055B, a 97.37% decline from 2022.
  • Viatris annual income after taxes for 2022 was $2.079B, a 263.79% decline from 2021.
  • Viatris annual income after taxes for 2021 was $-1.269B, a 89.45% increase from 2020.
Viatris Annual Income After Taxes
(Millions of US $)
2023 $55
2022 $2,079
2021 $-1,269
2020 $-670
2019 $17
2018 $353
2017 $696
2016 $480
2015 $848
2014 $933
2013 $627
2012 $643
2011 $539
2010 $346
2009 $248
Viatris Quarterly Income After Taxes
(Millions of US $)
2024-09-30 $95
2024-06-30 $-326
2024-03-31 $114
2023-12-31 $-766
2023-09-30 $332
2023-06-30 $264
2023-03-31 $225
2022-12-31 $1,011
2022-09-30 $354
2022-06-30 $314
2022-03-31 $399
2021-12-31 $-264
2021-09-30 $312
2021-06-30 $-279
2021-03-31 $-1,038
2020-12-31 $-916
2020-09-30 $186
2020-06-30 $39
2020-03-31 $21
2019-12-31 $21
2019-09-30 $190
2019-06-30 $-169
2019-03-31 $-25
2018-12-31 $51
2018-09-30 $177
2018-06-30 $38
2018-03-31 $87
2017-12-31 $244
2017-09-30 $88
2017-06-30 $297
2017-03-31 $66
2016-12-31 $418
2016-09-30 $-120
2016-06-30 $168
2016-03-31 $14
2015-12-31 $195
2015-09-30 $429
2015-06-30 $168
2015-03-31 $57
2014-12-31 $191
2014-09-30 $499
2014-06-30 $127
2014-03-31 $117
2013-12-31 $181
2013-09-30 $159
2013-06-30 $179
2013-03-31 $108
2012-12-31 $162
2012-09-30 $212
2012-06-30 $139
2012-03-31 $129
2011-12-31 $130
2011-09-30 $157
2011-06-30 $147
2011-03-31 $105
2010-12-31 $21
2010-09-30 $144
2010-06-30 $87
2010-03-31 $94
2009-12-31 $47
2009-09-30 $-4
2009-06-30 $96
2009-03-31 $109
Sector Industry Market Cap Revenue
Medical Medical Services $15.958B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.361B 11.58
Cencora (COR) United States $48.280B 17.81
DiDi Global (DIDIY) China $22.212B 0.00
Natera (NTRA) United States $22.082B 0.00
ICON (ICLR) Ireland $17.675B 15.74
Avantor (AVTR) United States $14.143B 21.20
Revvity (RVTY) United States $13.634B 23.68
CochLear (CHEOY) Australia $12.777B 0.00
Solventum (SOLV) United States $12.233B 0.00
BioMerieux (BMXMF) France $11.895B 0.00
Medpace Holdings (MEDP) United States $10.498B 29.58
Charles River Laboratories (CRL) United States $10.011B 19.34
HealthEquity (HQY) United States $9.104B 49.41
Doximity (DOCS) United States $8.999B 52.97
Sonic Healthcare (SKHHY) Australia $8.862B 0.00
Bausch + Lomb (BLCO) Canada $6.892B 32.08
Life Times (LTH) United States $5.081B 33.63
Organon (OGN) United States $3.935B 3.97
Sotera Health (SHC) United States $3.631B 19.42
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.925B 33.35
Concentras Parent (CON) United States $2.789B 0.00
PACS (PACS) United States $2.515B 0.00
Alignment Healthcare (ALHC) United States $2.310B 0.00
Ardent Health Partners (ARDT) United States $2.259B 0.00
Premier (PINC) United States $2.195B 11.42
GeneDx Holdings (WGS) United States $2.162B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GoodRx Holdings (GDRX) United States $1.868B 49.00
Teladoc Health (TDOC) United States $1.828B 0.00
Progyny (PGNY) United States $1.315B 26.62
Pediatrix Medical (MD) United States $1.285B 12.57
CareDx (CDNA) United States $1.241B 0.00
Establishment Labs Holdings (ESTA) $1.206B 0.00
AMN Healthcare Services Inc (AMN) United States $0.984B 6.66
Embecta (EMBC) United States $0.797B 5.32
QDM (QDMI) Hong Kong, SAR China $0.790B 0.00
Agilon Health (AGL) United States $0.779B 0.00
SBC Medicals (SBC) United States $0.674B 0.00
InnovAge Holding (INNV) United States $0.662B 0.00
Auna S.A (AUNA) Luxembourg $0.522B 0.00
Sonida Senior Living (SNDA) United States $0.474B 0.00
DocGo (DCGO) United States $0.434B 16.35
Enhabit (EHAB) United States $0.380B 32.87
COMPASS Pathways (CMPS) United Kingdom $0.302B 0.00
ModivCare (MODV) United States $0.254B 13.79
LifeMD (LFMD) United States $0.251B 0.00
Sera Prognostics (SERA) United States $0.221B 0.00
Biodesix (BDSX) United States $0.186B 0.00
Nutex Health (NUTX) United States $0.179B 0.00
Beauty Health (SKIN) United States $0.176B 0.00
MultiPlan (MPLN) United States $0.112B 0.00
So-Young (SY) China $0.086B 16.60
Ascend Wellness Holdings (AAWH) United States $0.085B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.046B 0.00
NeueHealth (NEUE) United States $0.041B 1.10
IceCure Medical (ICCM) Israel $0.032B 0.00
Co-Diagnostics (CODX) United States $0.032B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.021B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00